Abstract

Numerous candidate drugs are being evaluated for the treatment of nonalcoholic fatty liver disease (NAFLD), including some for the treatment of

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call